Chemed Secures New $450M Revolving Credit Facility

Chemed Corporation announced it has entered into an Amended and Restated Credit Agreement for a new five-year $450 million revolving credit facility. This facility includes $100 million for letters of credit and an expansion feature that provides the opportunity to increase the revolver by an additional $250 million. The interest rate is a floating rate generally based on SOFR plus an additional tiered rate. This agreement enhances Chemed's financial flexibility for its operations, which include VITAS Healthcare and Roto-Rooter.